Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Maya Ajmera, President & CEO of the Society for Science and Executive Publisher of Science News, spoke with David R. Liu, Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, ...

An innovative genome-editing tool promises to do what original CRISPR systems have struggled to achieve: insert entire genes, precisely and efficiently, into human DNA. “It could really be a big part ...

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and ...